Merck KGaA to sell CDMO business to Lonza for mid-triple-digit million euros

Merck KGaA, Darmstadt, Germany, announced a definitive agreement to sell its CDMO business within its Life Science sector to Lonza for a mid-triple-digit million-euro amount. The deal is expected to close in mid-2027, subject to regulatory approvals, and is intended to expand Lonza's US presence.

Detected & updated continuously · Source: Nebula